<DOC>
	<DOC>NCT02434549</DOC>
	<brief_summary>The purpose of this double-blinded, placebo-controlled study is to test if treatment with Botulinum toxin-A is effective in reducing chronic muscle-related pain in adults with spastic cerebral palsy.</brief_summary>
	<brief_title>Botulinum Toxin-A as a Treatment for Chronic Muscle-Related Pain in Adults With Spastic Cerebral Palsy: a Randomized Controlled Trial</brief_title>
	<detailed_description />
	<mesh_term>Paralysis</mesh_term>
	<mesh_term>Cerebral Palsy</mesh_term>
	<mesh_term>Muscle Spasticity</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins, Type A</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Age ≥ 18 years. Spastic Cerebral Palsy. Chronic pain, related to spastic muscle. Chronic pain defined as: 1)Recurring regional pain for at least three months AND 2)Pain intensity on average for the last 24 hours ≥3 on Numerical Rating Scale. Signed Informed consent. Allergy/hypersensitivity to Dysport® or any of its components. Pregnancy. Women who breastfeed their children. Treatment with Botulinum toxinA within the last five months. If there has been dose changes in any muscletone altering medication within two weeks of Visit 1. A clear degenerative cause behind the pain as elucidated by the clinical examination (e.g. history of osteoarthritis). Intellectual disability and/or communication impairment that disable the individual from answering the questionnaires and giving informed consent.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Randomized Controlled Trial</keyword>
	<keyword>Placebo Controlled</keyword>
	<keyword>Double Blinded</keyword>
	<keyword>Botulinum Toxin Type A</keyword>
	<keyword>Adults</keyword>
	<keyword>Pain</keyword>
	<keyword>Spasticity</keyword>
	<keyword>Cerebral Palsy, Spastic</keyword>
	<keyword>Dysport</keyword>
</DOC>